Oncology Grand Rounds Series: Part 10 — PARP Inhibition in the Management of Common Cancers (Webinar Audio Proceedings)

Emmanuel S Antonarakis, MD
Professor of Oncology and Urology
Johns Hopkins University
The Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland
Gretchen Santos Fulgencio, MSN, FNP-BC
University of California, San Francisco
Berkeley, California
Kathleen Moore, MD
The Virginia Kerley Cade Endowed
Chair in Cancer Development
Associate Director
Clinical Research
Director, Oklahoma TSET Phase I Program
Stephenson Cancer Center
Associate Professor
Section of Gynecologic Oncology
Director, Gynecologic Oncology Fellowship
Department of Obstetrics and Gynecology
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma
Joyce O’Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Breast Cancer Research Program
Texas Oncology
US Oncology
Dallas, Texas
Michael J Pishvaian, MD, PhD 
Associate Professor
Department of Oncology
Director of the Gastrointestinal
Developmental Therapeutics
and Clinical Research Programs at
the NCR Kimmel Cancer Center
at Sibley Memorial Hospital
Johns Hopkins University School of Medicine
Washington, DC
Deborah Wright, MSN, APRN, CNS
Phase I Clinical Nurse Specialist
Oncology Infusion APP Team Lead
Stephenson Cancer Center
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma
Neil Love, MD
Research To Practice
Miami, Florida